Chris Roberts was CEO Cochlear Limited (ASX:COH) for 11 years to August 2015.
He is a non-executive director of ResMed Inc (NYSE: RMD) and OncoSil Medical Limited (ASX: OSL).
He is a PLuS Alliance Professor at UNSW, King’s College London and Arizona State University.
He is a board member of: Innovation Australia, Jobs For NSW, Monash University Industry Advisory Council, UTS VC’s Industry Advisory Board; UNSW Medicine Advisory Council, the Health Innovation Advisory Committee (an NHMRC principal committee), and Centenary Institute.
He is an Honorary Fellow of the Australian Institute of Business and Economics (UQ).